ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023

$ 23.50

4.9
(430)
In stock
Description

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation (CRO), finishes the second half

ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023

ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023 - San Francisco Biotechnology Network

Viatris recognised as a Top Employer 2024 in the UK for the second consecutive year

ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023

Stock Market News 2023-12-18

ICLR, Detailed Quotes

ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023

Icon Plc (ICLR) Stock Price History

ICLR, Icon Plc